This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
PDCO or WST: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PDCO vs. WST: Which Stock Is the Better Value Option?
Intuitive Surgical (ISRG) Up on Solid Preliminary Q4 Results
by Zacks Equity Research
Higher revenues and growth in worldwide da Vinci procedure volume benefit Intuitive Surgical's (ISRG) preliminary Q4 results.
Veeva Systems Boosts Product Portfolio With New Application
by Zacks Equity Research
Veeva Systems (VEEV) introduces Veeva Vault Payments, which is likely to bolster the company's already robust product portfolio.
Varian (VAR) Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Varian (VAR) gains from several positive developments.
Here's Why You Should Invest in HMS Holdings (HMSY) Stock Now
by Zacks Equity Research
HMS Holdings (HMSY) is gaining traction from the growing PI and TPM analytical services.
Amedisys Gains on Favorable Demography, New Hospice Buyouts
by Zacks Equity Research
Amedisys (AMED) is steadily benefiting from its recent takeovers of hospice care providers, namely RoseRock Healthcare and Compassionate Care Hospice.
Exact Sciences Rides on Cologuard, Eyes Merger Synergies
by Zacks Equity Research
Exact Sciences (EXAS) continues to make a notable progress with its Cologuard business.
Myriad Genetics' GUIDED Clinical Trial Outcome Encouraging
by Zacks Equity Research
The result of this clinical trial is a major stride forward in Myriad Genetics' (MYGN) commitment toward strengthening its portfolio of depressive disorder treatments.
Here's Why You Should Add STERIS (STE) to Portfolio Now
by Zacks Equity Research
Investor confidence is high on STERIS (STE) stock for now, thanks to its solid prospects.
Here's Why You Should Retain Surmodics (SRDX) Stock for Now
by Zacks Equity Research
Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.
LabCorp (LH) Grows on Solid Diagnostics Arm Despite PAMA Headwinds
by Urmimala Biswas
LabCorp's (LH) Diagnostics business flourishes organically in terms of both revenues and volumes despite additional price reductions due to Protecting Access to Medicare Act (PAMA).
Here's Why You Should Hold on to Phibro (PAHC) Stock Now
by Zacks Equity Research
Investors can retain Phibro (PAHC) stock for now, thanks to its solid prospects.
Illumina Stock Slips on Pacific Biosciences Deal Termination
by Zacks Equity Research
Per Illumina (ILMN), the lengthy route to achieve regulatory nods for the transaction induces uncertainty about the ultimate outcome of the integration.
Here's Why You Should Hold on to QIAGEN (QGEN) Stock Now
by Zacks Equity Research
Investors can retain QIAGEN (QGEN) stock for now, thanks to its solid prospects.
Here's Why You Should Hold on to Insulet (PODD) Stock Now
by Zacks Equity Research
Investors can retain Insulet (PODD) stock for now on the back of its solid prospects.
Here's Why You Should Hold on to Intersect ENT (XENT) for Now
by Zacks Equity Research
Investors can retain Intersect ENT (XENT) stock for now, courtesy of its solid prospects.
Here's Why You Should Hold on to Intuitive Surgical for Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction remains a concern.
Here's Why You Should Invest in Patterson Companies Stock Now
by Zacks Equity Research
Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts.
Here's Why You Should Retain OPKO Health (OPK) Stock for Now
by Zacks Equity Research
OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.
HMS Holdings Acquires Nebraska-Based Intrado's Accent Unit
by Zacks Equity Research
The latest deal is likely to boost HMS Holdings' (HMSY) Payment Integrity solutions business.
Here's Why You Should Hold on to Masimo (MASI) Stock Now
by Zacks Equity Research
Masimo (MASI) raises revenue and earnings guidance for 2019.
6 MedTech Stocks That are Set to Beat the Market in 2020
by Trina Mukherjee
Banking on the three key trends, we zero in on six MedTech stocks that are likely to deliver stellar performance in 2020.
Masimo (MASI) Expands Partnership with Texas-Based Drager
by Zacks Equity Research
Masimo (MASI) sees a slew of developments in recent times.
Hill-Rom (HRC) Rides on International Growth, New Launches
by Urmimala Biswas
Hill-Rom (HRC) launches RetinaVue 700 Imager, EarlySense and WatchCare in 2019.
LHC Group Expands Partnership With Ochsner Health System
by Zacks Equity Research
LHC Group (LHCG) sees major expansion in partnerships of late.